ANXA2 and hepatocellular carcinoma: In summary, we demonstrate that overexpression of UBAP2 promotes ubiquitination and the degradation of Annexin A2, thus impairs the progression of HCC, indicating that UBAP2 appear as a novel marker for predicting prognosis and a therapeutic target for HCC.